Strateos Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
152
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$56M
- Investors
-
25
Strateos General Information
Description
Developer of a robotic cloud lab platform designed to accelerate drug discovery and synthetic biology research. The company's platform automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs, enabling pharmaceutical partners to rapidly and efficiently discover new drug candidates.
Contact Information
Website
www.strateos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Enterprise Systems (Healthcare)
Primary Office
- 3565 Haven Avenue
- Suite 3
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Strateos Timeline
Strateos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 08-Jun-2021 | $56M | 000.00 | 00000 | Completed | Generating Revenue |
| 3. Later Stage VC (Series A) | 03-Jun-2019 | 000.00 | 000.00 | 00000 | Completed | Startup |
| 2. Seed Round | $13M | $13M | 0000 | Completed | Startup | |
| 1. Merger of Equals | 03-Jun-2019 | Completed | Startup |
Strateos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A3 | 0,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00 |
| Seed 2 | 7,260,466 | $0.000100 | $0.09 | $1.18 | $1.18 | 1x | $1.18 | 8.41% |
| Seed 1 | 4,190,792 | $0.000100 | $0.09 | $1.11 | $1.11 | 1x | $1.11 | 4.86% |
Strateos Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a robotic cloud lab platform designed to accelerate drug discovery and synthetic biology research. The comp
Discovery Tools (Healthcare)
Menlo Park, CA
152
As of 2023
000.00
0000
0000-00-00
00000000000
000.00
000000
m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
000000000 00000 (000
Abingdon, United Kingdom
00
As of 0000
00.000
0000000000 0
00.000
000000
dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000000000000
London, United Kingdom
0
As of 0000
00.000
000000&0
00.000
Add Comparison
Strateos Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arctoris | Venture Capital-Backed | Abingdon, United Kingdom | 00 | 00.000 | 0000000000 0 | 00.000 |
| 0000000 00000000 | Formerly VC-backed | London, United Kingdom | 0 | 00.000 | 000000&0 | 00.000 |
| 00000000 | Private Equity-Backed | Chicago, IL | 000000000000 |
Strateos Patents
Strateos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230004886-A1 | Systems and methods for performing experiments at remote laboratories | Pending | 02-Jul-2021 | 00000000000 | |
| US-20230004885-A1 | Systems and methods for processing experimental workflows at remote laboratories | Pending | 02-Jul-2021 | 00000000000 | |
| US-20230004909-A1 | Systems and methods for processing experimental requests at remote laboratories | Pending | 02-Jul-2021 | 000000000000 | |
| US-20230003753-A1 | Systems and methods for managing experimental requests at remote laboratories | Pending | 02-Jul-2021 | 000000000000 | |
| US-20220362773-A1 | Devices and methods for handling biological specimens | Pending | 17-May-2021 | B01L3/50855 |
Strateos Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Fischer-Colbrie | President, Board Member & Chief Executive Officer | ||
| Christopher Krueger | Chief Financial Officer | ||
| David Lynch Ph.D | Chief Business Officer | ||
| Jason Pontin | Chairman | ||
| Mara Aspinall | Vice Chairman |
Strateos Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jason Pontin | Self | Chairman | 000 0000 |
| Jeffrey Finer Ph.D | Transcriptic | Chairman | 000 0000 |
| Joshua Wolfe | Lux Capital | Board Member | 000 0000 |
| Mara Aspinall | Self | Vice Chairman | 000 0000 |
Strateos Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Strateos Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 500 Global | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Ally Bridge Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Alumni Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Baidu Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bennu Venture Group | Venture Capital | Minority | 000 0000 | 000000 0 |
Strateos Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 | 03-Jun-2019 | 0000000000 | Laboratory Services (Healthcare) | ||
| 3Scan | 26-Apr-2019 | Merger/Acquisition | Diagnostic Equipment |